[go: up one dir, main page]

WO2009056754A3 - Utilisation de l ' econazole ou ses sels dans le traitement de l' acne et des dermites seborrheiques - Google Patents

Utilisation de l ' econazole ou ses sels dans le traitement de l' acne et des dermites seborrheiques Download PDF

Info

Publication number
WO2009056754A3
WO2009056754A3 PCT/FR2008/051934 FR2008051934W WO2009056754A3 WO 2009056754 A3 WO2009056754 A3 WO 2009056754A3 FR 2008051934 W FR2008051934 W FR 2008051934W WO 2009056754 A3 WO2009056754 A3 WO 2009056754A3
Authority
WO
WIPO (PCT)
Prior art keywords
econazole
salts
treating acne
acne
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2008/051934
Other languages
English (en)
Other versions
WO2009056754A9 (fr
WO2009056754A2 (fr
Inventor
Philippe Andres
Pascale Mauvais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of WO2009056754A2 publication Critical patent/WO2009056754A2/fr
Publication of WO2009056754A9 publication Critical patent/WO2009056754A9/fr
Publication of WO2009056754A3 publication Critical patent/WO2009056754A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention a pour objet l'utilisation d'une quantité efficace d'au moins un composé choisi parmi l'éconazole et ses sels pour la préparation d'une composition pharmaceutique pour traiter et/ou prévenir au moins une pathologie choisie parmi l'acné, les dermites séborrhéiques et les désordres de la séborrhée.
PCT/FR2008/051934 2007-10-26 2008-10-27 Utilisation de l ' econazole ou ses sels dans le traitement de l' acne et des dermites seborrheiques Ceased WO2009056754A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0758635 2007-10-26
FR0758635 2007-10-26

Publications (3)

Publication Number Publication Date
WO2009056754A2 WO2009056754A2 (fr) 2009-05-07
WO2009056754A9 WO2009056754A9 (fr) 2009-06-25
WO2009056754A3 true WO2009056754A3 (fr) 2009-08-13

Family

ID=39166336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/051934 Ceased WO2009056754A2 (fr) 2007-10-26 2008-10-27 Utilisation de l ' econazole ou ses sels dans le traitement de l' acne et des dermites seborrheiques

Country Status (1)

Country Link
WO (1) WO2009056754A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022060744A1 (fr) * 2020-09-15 2022-03-24 Eric Rauch Méthodes de traitement de l'alopécie androgénique et/ou d'états cutanés

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446145A (en) * 1980-01-24 1984-05-01 Janssen Pharmaceutica N.V. Anti-microbial compositions for the topical treatment of acne vulgaris
EP0270316A2 (fr) * 1986-12-04 1988-06-08 Pfizer Inc. Compositions topiques contenant des imidazoles 1-substitués et des agents non-steroides anti-inflammatoires pour le traitement de l'acné
WO1993007847A1 (fr) * 1991-10-15 1993-04-29 Kenneth Vincent Mason Composition antiseborrheique
WO2000015168A1 (fr) * 1998-09-10 2000-03-23 Danclar Wayne G Traitement antifongique topique contre les pellicules
WO2006004795A2 (fr) * 2004-06-25 2006-01-12 The Johns Hopkins University Inhibiteurs d'angiogenese
CN1931165A (zh) * 2006-09-21 2007-03-21 西北农林科技大学 一种硝酸益康唑纳米乳抗真菌药物及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446145A (en) * 1980-01-24 1984-05-01 Janssen Pharmaceutica N.V. Anti-microbial compositions for the topical treatment of acne vulgaris
EP0270316A2 (fr) * 1986-12-04 1988-06-08 Pfizer Inc. Compositions topiques contenant des imidazoles 1-substitués et des agents non-steroides anti-inflammatoires pour le traitement de l'acné
WO1993007847A1 (fr) * 1991-10-15 1993-04-29 Kenneth Vincent Mason Composition antiseborrheique
WO2000015168A1 (fr) * 1998-09-10 2000-03-23 Danclar Wayne G Traitement antifongique topique contre les pellicules
WO2006004795A2 (fr) * 2004-06-25 2006-01-12 The Johns Hopkins University Inhibiteurs d'angiogenese
CN1931165A (zh) * 2006-09-21 2007-03-21 西北农林科技大学 一种硝酸益康唑纳米乳抗真菌药物及其制备方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DANIEL F: "The seborrhoeic skin", REVUE DU PRATICIEN 1985 FR, vol. 35, no. 53, 1985, pages 3215 - 3224, XP008092028, ISSN: 0035-2640 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 26 March 2007 (2007-03-26), OUYANG, WUQING ET AL: "Manufacture of antifungal agent econazole nitrate nanoemulsion", XP002481923, retrieved from STN Database accession no. 2007:339427 *
GERNY H: "The modern treatment of acne vulgaris", THERAPEUTISCHE UMSCHAU 1989 CH, vol. 46, no. 2, 1989, pages 118 - 122, XP008092030, ISSN: 0040-5930 *
LEMAISTRE R ET AL: "Seborrheic dermatitis in children", GAZETTE MEDICALE 1986 FR, vol. 93, no. 2, 1986, pages 41 - 43, XP008092027, ISSN: 0760-758X *

Also Published As

Publication number Publication date
WO2009056754A9 (fr) 2009-06-25
WO2009056754A2 (fr) 2009-05-07

Similar Documents

Publication Publication Date Title
WO2009051670A3 (fr) Compositions et procédés destinés au traitement de maladies ophtalmiques
WO2014144100A3 (fr) Stimulateurs de sgc
CL2007003049A1 (es) Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos.
WO2008070129A3 (fr) Compositions et procédés pour le traitement de maladie inflammatoire
WO2012021629A3 (fr) Nouveaux agonistes du récepteur dopaminergique d3 pour traiter la dyskinésie dans la maladie de parkinson
WO2007126957A3 (fr) Nouveaux composés
WO2009127642A3 (fr) Utilisation d’inhibiteurs de lrrk2 pour maladies neurodégénératives
WO2010045258A3 (fr) Modulateurs spirocycliques de gpr40
WO2009036175A3 (fr) Inhibiteur de f1f0-atpase et procédés associés
BR112013004835A2 (pt) ''compostos,composição fungicida,método para controlar doenças de planta causadas por patógenos de planta fúngicos e método''.
WO2012054535A3 (fr) Composés, compositions et méthodes utiles pour la mobilisation du cholestérol
WO2008110314A8 (fr) Fluoroalkylphénylamidines et leur utilisation comme fongicides
WO2008070268A3 (fr) Compositions pharmaceutiques
HK1219435A1 (zh) 用於加速斑块消退的组合物和治疗方法
WO2011014825A3 (fr) Petites molécules anti-angiogéniques et procédés d'utilisation
WO2011090270A3 (fr) Composition contenant de l'osmotine pour prévenir et traiter des troubles neurologiques
PT2056814E (pt) Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
BR112012003464A2 (pt) composto, composição farmacêutica, usos de uma composição farmacêutica e de um composto, e, método para tratar uma doença ou um distúrbio."
WO2012118308A3 (fr) Composition contenant un dérivé de pyrazole destinée à prévenir et à traiter les maladies cardiovasculaires
WO2011023367A3 (fr) Promédicaments bisphosphonates
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
WO2009051223A1 (fr) Composition pharmaceutique pour le traitement de la cataracte
WO2009145591A3 (fr) Composés de phényl-pipérazine, composition pharmaceutique les comprenant, et utilisation associée
WO2010098583A3 (fr) Nouveau procédé de préparation de composés de statine ou des sels de ceux-ci, et composés intermédiaires utilisés dans ce procédé
WO2010102154A3 (fr) Composés acides biaryl oxyacétiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08843365

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08843365

Country of ref document: EP

Kind code of ref document: A2